UVISA Health
UVISA Health is developing a reusable, drug-free home-treatment device that uses light therapy to relieve symptoms of Bacterial Vaginosis and Candidiasis. The insertable device disrupts microbial cell membranes to eliminate harmful microbes while allowing good bacteria to repopulate the vaginal microbiome. The device is designed as a dual-purpose solution for both fungal and bacterial infections, priced at 1200 DKK (£139.99).
- Medical Devices
- Healthcare Technology
- Hardware
Funding
Founders
Founder details are not available yet.
Product
Problem
Vaginal infections such as Bacterial Vaginosis (BV) and Candidiasis (thrush) affect millions of women worldwide, yet current treatment options are largely pharmacological, requiring lengthy treatment durations of up to 14 days and carrying adverse side effects. These infections are also frequently misdiagnosed, leading to ineffective treatment and recurrent suffering.
Solution
UVISA Health is developing a reusable, drug-free home-treatment device that uses light therapy to relieve symptoms of common vaginal infections. The insertable device directs light inside the vagina and over the vulva, disrupting microbial cell membranes to eliminate harmful microbes while allowing good bacteria to repopulate the vaginal microbiome. This offers a discrete, cost-effective alternative to pharmacological treatments, empowering women to manage their health at home without frequent doctor visits or pharmacy runs. The device is designed as a dual-purpose solution, treating both fungal (yeast) and bacterial vaginal infections, so users do not need to worry about misdiagnosis.
Target Audience
Primary users are women who experience recurrent vaginal infections—specifically Bacterial Vaginosis and Candidiasis—and who seek alternatives to lengthy pharmacological treatments with side effects, including those who have experienced misdiagnosis and are looking for a home-based solution.
Features
- Reusable home-treatment device using light therapy to target harmful bacteria and yeast without pharmaceuticals
- Dual-purpose design treats both Bacterial Vaginosis (BV) and Candidiasis (thrush), eliminating the need for accurate self-diagnosis
- Light-based mechanism disrupts microbial cell membranes without harming human vaginal tissue
- Insertable device designed for discrete, at-home use, reducing reliance on clinic visits and pharmacy treatments
- Device priced at 1200 DKK (£139.99) as a one-time purchase versus recurring costs of repeated pharmacological treatments